Sigal Charles Elliott 4
4 · Adaptimmune Therapeutics PLC · Filed Jul 3, 2023
Insider Transaction Report
Form 4
Sigal Charles Elliott
Director
Transactions
- Award
Option to purchase Ordinary Shares
2023-07-03+933,317→ 933,317 totalExercise: $0.16From: 2024-07-03Exp: 2033-07-03→ Ordinary Shares (933,317 underlying)
Footnotes (1)
- [F1]The exercise price was converted from GBP0.12 based on an exchange rate of $U.S. 1.270841 to GBP1.00. The actual exercise price will be the pounds sterling amount.